Eric Morand, MD, PhD

Monash University
Clayton, Victoria, Australia

Eric Morand is Professor of Medicine at Monash University and Director of Rheumatology at Monash Health. His group studies glucocorticoid biology, lupus outcomes and clinical endpoint development.

Presentation(s):

• 1501: Lupus Low Disease Activity State (LLDAS) Achievement with Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in a Phase 2 Trial in SLE

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.

• 2261: Burden of Flare and Organ Damage in Systemic Lupus Erythematosus (SLE) in the Asia Pacific Region: A Multicenter Cohort Study

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.

• 2262: Identifying Important Domains for Inclusion in a Novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): Results of a Modified Delphi Study

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.

• 2263: Disease Activity Progression in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.

• 2334: Remission Attainment in Patients with Systemic Lupus Erythematosus Treated with Anifrolumab Compared with Placebo over a 4-Year Period

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.

• 2444: Development of Engineered Smith-Specific Regulatory T Cells to Treat Lupus Nephritis

  Tuesday, November 14, 2023
  2:15 PM – 2:25 PM PT

  Disclosure information not submitted.